{"id":"worldbank.antiretroviral-therapy-coverage.lby.annual","dataset_id":"worldbank-antiretroviral-therapy-coverage","indicator":"antiretroviral-therapy-coverage","geography":"LBY","frequency":"annual","unit":"percent","start_period":"2000","end_period":"2023","org":"World Bank","original_indicator":"SH.HIV.ARTC.ZS","url":"https://api.worldbank.org/v2","retrieved_at":"2026-11-07T07:57:03+00:00","version":"1","geography_name":"Libya","region":"Middle East, North Africa, Afghanistan & Pakistan","observations":[{"period":"2000","value":12.0,"flags":""},{"period":"2001","value":13.0,"flags":""},{"period":"2002","value":15.0,"flags":""},{"period":"2003","value":13.0,"flags":""},{"period":"2004","value":18.0,"flags":""},{"period":"2005","value":20.0,"flags":""},{"period":"2006","value":23.0,"flags":""},{"period":"2007","value":27.0,"flags":""},{"period":"2008","value":32.0,"flags":""},{"period":"2009","value":38.0,"flags":""},{"period":"2010","value":44.0,"flags":""},{"period":"2011","value":50.0,"flags":""},{"period":"2012","value":52.0,"flags":""},{"period":"2013","value":51.0,"flags":""},{"period":"2014","value":55.0,"flags":""},{"period":"2015","value":59.0,"flags":""},{"period":"2016","value":61.0,"flags":""},{"period":"2017","value":62.0,"flags":""},{"period":"2018","value":68.0,"flags":""},{"period":"2019","value":53.0,"flags":""},{"period":"2020","value":50.0,"flags":""},{"period":"2021","value":49.0,"flags":""},{"period":"2022","value":47.0,"flags":""},{"period":"2023","value":50.0,"flags":""}],"indicator_name":"Antiretroviral therapy coverage","topic":"Health","source":"worldbank","provenance":{"organization":"World Bank","original_indicator":"SH.HIV.ARTC.ZS","url":"https://api.worldbank.org/v2","retrieved_at":"2026-11-07T07:57:03+00:00","version":"1","license":"see source"}}